Suppr超能文献

良性多发性硬化症真的是良性的吗?除了扩展残疾状态量表(EDSS)之外,一个有意义的分类还必须考虑哪些因素。

Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.

作者信息

Ellenberger David, Flachenecker Peter, Haas Judith, Hellwig Kerstin, Paul Friedemann, Stahmann Alexander, Warnke Clemens, Zettl Uwe K, Rommer Paulus S

机构信息

German MS-Register by the German MS Society, MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany.

Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany.

出版信息

Mult Scler Relat Disord. 2020 Nov;46:102485. doi: 10.1016/j.msard.2020.102485. Epub 2020 Sep 3.

Abstract

BACKGROUND

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease with an unpredictable course that has a broad clinical spectrum and progresses over time. If a person with MS (PwMS) shows overall mild to moderate disability even after a long duration of disease, the term benign MS (BMS) is used. However, there is currently no generally accepted definition of BMS. Most definitions are based on EDSS in connection with disease duration, i.e. EDSS ≤3.0 after 15 years' disease duration. The question arises whether focusing on EDSS alone is adequate for classifying the disease course taking into account that 'hidden' or 'soft' symptoms are not sufficiently covered by this instrument. The aims of the study are to assess the prevalence of BMS in one of the largest patient cohorts, to describe the prevalence of patients without disabilities and to assess the further disability progression of these patients over another 15 years.

METHODS

Based on data exported from the German MS Registry, PwMS with a disease duration of 15 years or more were included in the analyses. PwMS were divided into BMS (EDSS ≤3.0) or non-benign (NBMS, EDSS >3.0).

RESULTS

Out of 31,824 PwMS included in the German MS Register, we identified 10,874 patients with a disease duration ≥15 years of whom 4,511 (42%) showed an EDSS ≤3.0 fulfilling the criterion of benign MS. In the subgroup with EDSS measured exactly at 15 years' disease duration, the proportion was 54%. This proportion decreased continuously with increasing disease duration and fell to 30% after 30 years. Female sex (hazard ratio [HR]: 0.84) was associated with BMS, while a progressive (HR: 2.09) and late disease onset (HR: 1.29) were associated with NBMS (p<0.001). With a more rigorous definition of BMS (EDSS ≤1.0, absence of disability, and active employment), only 580 (13%) of the initial BMS remained 'benign'.

CONCLUSION

Our data propose an alternative definition (EDSS ≤1.0, absence from any disability, and the ability to work after 15 years of disease duration) which might truly reflect BMS.

摘要

背景

多发性硬化症(MS)是一种神经炎症性和神经退行性疾病,病程不可预测,临床谱广泛且随时间进展。如果一名多发性硬化症患者(PwMS)即使在患病很长时间后总体仍表现为轻度至中度残疾,则使用良性MS(BMS)这一术语。然而,目前尚无被普遍接受的BMS定义。大多数定义基于扩展残疾状态量表(EDSS)并结合病程,即病程15年后EDSS≤3.0。考虑到该工具未充分涵盖“隐藏”或“软性”症状,仅关注EDSS是否足以对疾病进程进行分类这一问题便随之而来。本研究的目的是评估最大患者队列之一中BMS的患病率,描述无残疾患者的患病率,并评估这些患者在接下来15年中的残疾进展情况。

方法

基于从德国MS注册中心导出的数据,病程达15年或更长时间的PwMS被纳入分析。PwMS被分为BMS(EDSS≤3.0)或非良性(NBMS,EDSS>3.0)。

结果

在德国MS注册中心纳入的31824名PwMS中,我们确定了10874名病程≥15年的患者,其中4511名(42%)的EDSS≤3.0,符合良性MS的标准。在病程恰好为15年时测量EDSS的亚组中,这一比例为54%。该比例随病程延长而持续下降,30年后降至30%。女性(风险比[HR]:0.84)与BMS相关,而疾病进展(HR:2.09)和发病较晚(HR:1.29)与NBMS相关(p<0.001)。采用更严格的BMS定义(EDSS≤1.0、无残疾且在职)时,最初的BMS中只有580名(13%)仍为“良性”。

结论

我们的数据提出了一种替代定义(病程15年后EDSS≤1.0、无任何残疾且有工作能力),这可能真正反映BMS。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验